GO
Loading...

Onyx Rejects Amgen's Takeover Bid

Monday, 1 Jul 2013 | 11:08 AM ET

Onyx is essentially putting itself up for sale to the highest bidder, reports CNBC's David Faber, although it did reject an unsolicited bid from Amgen because the board believed it undervalued the company.